Register entry

ROVI Pharma Industrial Services S.A.

Registered sites
4
Drug products
16
Live patents
0
Countries
1
Base
Spain
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingLabellingFinished drug manufacturePackagingsterilize
Sites

Facilities

4
SiteLocationOperationsFEI
Rovi Pharma Industrial Services SAAlcala de HenaresSpainAnalytical testing, Labelling, Finished drug manufacture, Packaging3002989591
Alloga Log�stica Espa�a S.L.IllescasSpainFinished drug manufacture3027545805
ROVI Pharma Industrial Services S.A.MadridSpainAnalytical testing, Labelling, Finished drug manufacture, Packaging, sterilize3007512884
ROVI PHARMA INDUSTRIAL SERVICES S.A.San Sebasti�n de los ReyesSpainAnalytical testing, Finished drug manufacture, Packaging3016688535
Catalogue

Marketed products

16

Showing 16 of 16.

BrandGeneric nameFormCategory
-CX-038839 OMICRON (XBB.1.5)INJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-CX-038839 OMICRON (XBB.1.5)INJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-Moderna COVID-19 VaccineINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-Moderna COVID-19 VaccineINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-Respiratory Syncytial Virus VaccineSUSPENSIONDRUG FOR FURTHER PROCESSING
-Respiratory Syncytial Virus VaccineSUSPENSIONDRUG FOR FURTHER PROCESSING
-Sterile Water for InjectionINJECTIONBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for InjectionINJECTIONBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for InjectionINJECTIONBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for InjectionINJECTIONBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for InjectionINJECTIONBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for injectionINJECTIONBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Taurolidine, HeparinSOLUTIONDRUG FOR FURTHER PROCESSING
-Taurolidine, HeparinSOLUTIONDRUG FOR FURTHER PROCESSING
-alendronate sodium and cholecalciferolTABLETDRUG FOR FURTHER PROCESSING
-alendronate sodium and cholecalciferolTABLETDRUG FOR FURTHER PROCESSING
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.